Qure.ai
AI-powered medical imaging software (chest X-ray, CT, lung cancer, stroke, TB) sold to hospitals, health systems, governments, and pharma and medtech partners.
Qure.ai builds deep-learning tools that read radiology scans. Its products include qXR for chest X-rays, qER for head CT, qTrack for lung health management and a lung cancer detection platform launched in June 2026. It sells to hospitals, public health programs and pharma/medical device companies in many countries, mainly through software licensing. It raised a Series D of about $65M in September 2024, and total funding is reported at roughly $123M–$133M depending on the tracker. Its Indian entity reported revenue of about ₹190 Cr for FY2025, and Tracxn lists about 306 employees as of March 2026.
